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Abstract 
Background: The human immunodeficiency virus type 1 (HIV-1) genome (~9 kb RNA) is flanked by two long termi-
nal repeats (LTR) promoter regions with nine open reading frames, which encode Gag, Pol and Env polyproteins, four 
accessory proteins (Vpu, Vif, Vpr, Nef ) and two regulatory proteins (Rev, Tat). In this study, we carried out a genome-
wide and functional analysis of the HIV-1 genome in fission yeast (Schizosaccharomyces pombe).
Results: Each one of the HIV-1 genes was cloned and expressed individually in fission yeast. Subcellular localization 
of each viral protein was first examined. The effect of protein expression on cellular proliferation and colony forma-
tions, an indication of cytotoxicity, were observed. Overall, there is a general correlation of subcellular localization of 
each viral protein between fission yeast and mammalian cells. Three viral proteins, viral protein R (Vpr), protease (PR) 
and regulator of expression of viral protein (Rev), were found to inhibit cellular proliferation. Rev was chosen for fur-
ther analysis in fission yeast and mammalian cells. Consistent with the observation in fission yeast, expression of HIV-1 
rev gene also caused growth retardation in mammalian cells. However, the observed growth delay was neither due 
to the cytotoxic effect nor due to alterations in cell cycling. Mechanistic testing of the Rev effect suggests it triggers 
transient induction of cellular oxidative stress.
Conclusions: Some of the behavioral and functional similarities of Rev between fission yeast and mammalian cells 
suggest fission yeast might be a useful model system for further studies of molecular functions of Rev and other HIV-1 
viral proteins.
Keywords: HIV-1, Viral genome, Gene expression, Functional analysis, Fission yeast, Schizosaccharomyces pombe, 
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Background
The human immunodeficiency virus type 1 (HIV-1), 
like other retroviruses, is made up of an RNA encoded 
genome of approximately 9.7 kilobases (kb). Both ends of 
the RNA genome are flanked by a long terminal repeat 
(LTR) promoter region (Fig.  1). Between the two LTR 
regions, there are three polyproteins (Gag, Pol, Env), 
four accessory proteins (Vpu, Vif, Vpr, Nef) and two 
regulatory proteins (Rev, Tat). HIV-1 RNA also contains 
regulatory regions which are important for transcription 
initiation and polyadenylation.
The polyprotein Gag is required for both virion assem-
bly and maturation [1, 2]. The Gag protein is cleaved by 
viral protease into P17, P24, P7, and P6 proteins shortly 
after budding from the host cell [1]. P17 (MA) protein 
lies in the inner surface membrane of matured viral par-
ticles [3]. It is important for RNA targeting of the plasma 
membrane prior to viral assembly, incorporation of the 
Env glycoprotein into the viral particle [4, 5] and the 
particle release [6, 7]. P24 (Capsid domain, CA) protein 
forms a shell surrounding the viral RNA genome and 
core-associated proteins in mature virion. It plays various 
roles including incorporation of the Gag-Pol precursor 
into virions during viral assembly [8], recruitment of the 
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viral infectivity enhancing protein Cyclophilin A (CypA) 
[9–11], and early post entry [12]. P7 (Nucleocapsid, NC) 
plays important roles in the encapsulation and protection 
of viral RNA, promotion of viral assembly and in early 
post entry steps including reverse transcription [13]. P6 
is important for Vpr packaging into the viral particle and 
virus budding from the cell membrane [14].
The Pol protein is expressed as a Gag–Pol fusion prod-
uct since its gene lacks an initiation codon. It is subse-
quently cleaved by HIV-1 protease to produce MA, CA, 
NC, trans-frame protein (TF), viral enzymes protease 
(PR), reverse transcriptase (RT), and integrase (IN) [15]. 
PR cleaves the Gag and Pol precursors thus rendering the 
virion infectious [16]. RT is an asymmetric heterodimer 
with its main role to reverse transcribe viral RNA into 
pro-viral DNA prior to viral integration to host chromo-
somes [17]. Other functions of RT include RNA-directed 
DNA polymerase, DNA directed DNA polymerase and 
ribonuclease hybrid activities (RNase H) [18]. IN is active 
only as a tetramer and it is responsible for the integration 
of the linear double-stranded proviral DNA into the host 
cell chromosome [19].
The Env/gp160 protein is a precursor protein encoded 
by a spliced mRNA, which is subsequently cleaved by 
cellular proteases into the envelope gp120 surface mem-
brane protein (SU) and gp41 trans-membrane protein 
(TM) [20]. The gp120 surface subunit harbors the N-ter-
minal of the Gp160. It binds to cell receptors attaching 
virus to target cells and also regulates viral entry. Gp41 is 
the C-terminal 345-amino acid protein of gp160. It is also 
involved in the viral entry and mediation of fusion [21].
In addition to the retroviral Gag, Pol, and Env proteins, 
HIV-l produces four accessory proteins, i.e. Nef, Vif, Vpr 
and Vpu, and two regulatory protein, i.e. Tat, and Rev 
[22]. While Tat and Rev are required for viral replication, 
Nef, Vif, Vpr and Vpu are dispensable for viral prolifera-
tion in many of the in  vitro systems [23, 24]. However, 
they are often necessary for viral replication and patho-
genesis in vivo and for many of the essential viral func-
tions during the viral life cycle.
The fission yeast Schizosaccharomyces pombe (S. 
pombe) is a unicellular eukaryote of the Division Asco-
mycota. It is cylindrical and rounded at both ends. It 
reproduces meiotically by ascospores and proliferates 
asexually by cell division (fission). Its length and diam-
eter are about 7–12  µm and 3–4  µm, respectively [25, 
26]. It has a relative small genomic size of about 1.5 × 1 
07 bp in the haploid state [27]. S. pombe has many of the 
same fundamental cellular features as larger multicellu-
lar organisms which makes it very useful in many of the 
molecular-biological studies [25–28]. It contains gene 
slicing mechanism that is able to remove introns from 
genes of higher eukaryote and mammals [25, 27, 29]. 
Its signal-transduction system is able to transmit sig-
nals from the mating factor receptor through a G-pro-
tein-coupled system to the effectors [25]. The cell cycle 
is also similar to that in higher eukaryotes [27, 31]. For 
more than three decades, fission yeast has been used in 
many studies to investigate the structures, functions and 
expression of eukaryotic genes, especially from mamma-
lian origins [25, 27, 29, 31]. It should also be mentioned 
that our laboratory has been using fission yeast as a 
Fig. 1 Schematic diagram of HIV-1 genome. The total size of HIV-1 genome is approximately 9.7 kb. Each of the viral genes is drawing based on the 
relative orientation in the entire RNA genome. Arrows points to cleaved protein products. Dashed lines represent RNA splicing. The number in paren-
thesis is molecular weight of each protein. LTR long-term repeat, Gag group-specific antigen, MA matrix protein, CA capsid domain, NC nucleocapsid, 
TF trans-frame protein, Pol polymerases, PR protease, RT reverse transcriptase, IN integrase, Env envelope protein, SU surface membrane protein, TM 
trans-membrane protein, Vif viral infectivity factor, Vpr viral protein R, Vpu viral protein U, Nef negative regulatory factor, Rev regulator of expression 
of viral proteins, Tat trans-activator of transcription.
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model system to study the effect of HIV-1 Vpr on basic 
cellular functions in the past 20  years, which includes 
cell cycle G2/M regulation, nuclear transport and induc-
tion of cell death and apoptosis [31–36]. Results of those 
earlier studies have demonstrated the effects of Vpr are 
resembled, most of the time, to those of found in mam-
malian cells. Furthermore, this simple model system 
allowed us to discover new Vpr-specific activities that 
are otherwise difficult to uncover solely based on mam-
malian studies  [37–41]. Our intention in this study was 
therefore to expand and to test whether we could also 
use fission yeast as a host system to study other HIV-1 
proteins.
It should be mentioned that both fission yeast and bud-
ding yeast (Saccharomyces cerevisiae) have long been 
used to study various HIV-1 proteins. Some specific 
examples include HIV-1 Gag [31], Tat [32], Rev [33], Vpr 
[34], Vpx [35], Vpu [36], Integrase [42] and Protease [43], 
respectively. A number of reviews have also described 
the use of yeast as a model system for HIV-1 studies 
[44–47]. However, none of those early yeast studies has 
studied the whole HIV-1 genome all at once. Therefore 
our goal here was to carry out a genome-wide and func-
tional analysis by cloning and expressing every viral gene 
encoded by the HIV genome in fission yeast. Subcellular 
localizations and effects of these viral proteins on fission 
yeast cell proliferation and colony formation, an indica-
tion of cytotoxicity, were observed and analyzed.
Results
Subcellular localizations of HIV‑1 proteins in fission yeast
In order to determine the subcellular localization of HIV-1 
proteins in fission yeast, SP223 cells were transformed 
with a fission yeast expression pYZ3N plasmid producing 
each of the HIV-1 viral protein sequences in fusion with 
an N-terminal GFP [48]. The fission yeast strains con-
taining different viral proteins expressing plasmids were 
inoculated into liquid selective medium and the protein 
expression was induced following the removal of thiamine 
from the growth medium as described previously [34, 
49]. After cultured for 24–30 h (depending on the inten-
sity of green fluorescence), the GFP-viral fusion protein 
products were observed under a fluorescence microscope. 
As shown in Fig. 2a, GFP alone disperses throughout the 
cells indicating no preference of subcellular location. In 
contrast, the Gag protein aggregated in the cytoplasm 
of unknown sites. P17 protein was excluded from the 
nucleus and localized exclusively in the cytoplasm. P24 
protein was localized both in the nucleus and cell mem-
brane, while the P7 protein was predominantly localized 
in the nucleus. P6 was found distributed throughout the 
cell. The localizations of Pol proteins (P66, P51, IN, PR) 
and Env proteins (including Gp120 and Gp41) were 
monitored and shown in Fig. 2b. P66 was found more in 
the nucleus than in the cytoplasm; whereas P51 proteins 
were found exclusively in the cytoplasm. Consistent with 
the role of HIV-1 integrase, IN was indeed found more 
in the nucleus than in the cytoplasm. PR was distributed 
evenly throughout the cell, while Gp120 and Gp41 were 
localized more in the nucleus than in the cytoplasm. The 
subcellular distribution of HIV-1 accessory proteins (Vpr, 
Vpu, Vif, Nef, Rev, and Tat) was shown in Fig.  2c. Con-
sistent with previous findings with Vpr [48], it localizes 
predominantly in the nucleus. Similarly, Vif, Rev, and 
Tat all accumulated in the nucleus of yeast cells. Nuclear 
localization of Tat has also been reported in budding yeast 
previously [50]. Vpu in cytoplasm but Nef was distributed 
throughout the cell. Finally, the subcellular location pat-
terns observed in fission yeast were compared with that 
reported from mammalian cell studies. As summarized in 
Table 1, overall, there is a general correlation of the sub-
cellular localization of each viral protein between fission 
yeast and that of previously reported in mammalian cells. 
Effects of HIV‑1 gene expression on yeast colony formation
To determine potential cytotoxic effect of HIV-1 viral 
protein expression on fission yeast, yeast colony for-
mation, an indication of cellular growth and potential 
cytotoxicity, was measured. Fission yeast cells that were 
transformed with each one of the viral proteins via the 
inducible pYZ1N plasmids [48] were plated on selected 
agar plates under the gene-repressing (gene-Off) or gene-
inducing (gene-On) conditions (Fig.  3). Correct nucleo-
tide sequence of each viral gene carried on the pYZ1N 
plasmid was confirmed by Sanger sequencing. S. pombe 
cells transformed with pYZ1N-Vpr or an empty pYZ1N 
plasmid were used as positive and negative controls, 
respectively. We have reported previously that Vpr pre-
vents colony formation whereas pYZ1N plasmid has no 
cytotoxic effect on cells [34, 64]. As shown in Fig. 3, all 
HIV-1 viral gene-repressing (gene-Off) cells formed col-
onies as anticipated. On the gene-inducing (gene-On) 
plates, as expected, cells containing the empty pYZ1N 
plasmid formed colonies but HIV-1 Vpr prevented col-
ony formation. Most of the HIV-1 viral gene expressions 
in fission yeast did not show any cytotoxic effects as they 
formed the same sizes of colony as the pYZ1N control. 
In contrast, however, the fission yeast strains expressing 
rev and PR showed much reduced or no colony formation 
indicating inhibition of cell growth or possible cytotoxic 
effects following expression of the respective genes.
Effects of HIV‑1 rev gene expression on yeast cell growth
To further differentiate the inhibitory effect of HIV-1 
Rev protein on the cellular growth or toxicity of yeast 
cells, we measured the growth kinetics of S. pombe cells 
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Fig. 2 Subcellular localization of HIV-1 proteins in fission yeast. Fission yeast strains expressing normal GFP or N-terminally GFP-tagged HIV-1 
proteins were grown to a log phase in EMM selective media. The cells were re-inoculated into fresh media without thiamine (to induce gene 
expression) and grown for 24–30 h. The nuclei were stained with DAPI. The cells were examined using fluorescence microscopy for subcellular 
localizations of the GFP-tagged proteins with stained cellular nuclei. Each column represents different microscopic views: GFP, for protein subcellular 
location; DAPI, for localization of the nucleus; Merge, merging images of GFP and DAPI; and the “Contrast” is for the overall view of the cell. The Gag 
gene products are shown in a, the Pol and Env gene products in b, and the auxiliary and regulatory proteins in c. The scale bar represents 10 μm.
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with and without rev gene expression. S. pombe cells 
containing pYZ1N-rev and pYZ1N control vectors were 
grown under gene-repressing (+T) and gene-inducing 
(−T) conditions in liquid minimal and selective EMM 
medium. Cellular growth was measured by the optical 
density (OD) over time from 0 to 122 h (5 days). At the 
first 24 h, both cells grown at the same pace with a dou-
bling time of approx. 24 h. After 24 h of gene induction 
when the rev gene expression was fully expressed [34, 
65], the growth velocity of Rev-producing cells became 
slower than those without rev gene expression that was 
grown actively in a logarithmic fashion (Fig. 4a). By 48 h, 
i.e., 2  days after rev gene induction, the difference in 
growth between rev-expressing and rev-repressing cells 
reached to the maximum level. As control, the pYZ1N 
transformed yeast cells showed no difference in growth 
of neither gene-repressing nor gene-inducing condition. 
Rev causes growth delay but not cell death
Retarded cell growth could be an indication of cell death 
due to cytotoxicity. So we checked whether the growth 
delay caused by Rev was due to cell death. A semi-quan-
titative colony dot dilution assay was used, which quanti-
fied the ability of individual cells to form colonies on agar 
plate. All of the cells expressing rev formed colonies with 
expected numbers on each agar plate although the colony 
sizes were much smaller (Fig. 4b). This observation sug-
gested that Rev causes growth delay but not cell death. 
Therefore, Rev causes growth delay but not cell death.
Rev does not affect cell cycling of fission yeast
Because Rev affects cellular growth of fission yeast cells, 
we were interested in testing whether it affects the dis-
tribution of cell cycles. The cell cycle profile of S. pombe 
cells containing rev-expressing plasmid was monitored 
by flow cytometry. In standard EMM medium, S. pombe 
cells normally reside predominantly in the G2 phase of 
the cell cycle [66]. If Rev induces G1 delay, we should 
expect a shift of the predominantly G2 cell population 
to G1 after the production of Rev protein. Similarly, Rev-
induced G2 delay should be represented by no shift of G2 
cell population to G1 in the EMM medium. In this exper-
iment, production of HIV-1 Rev protein did not change 
the cell cycle profile (Fig.  4c). Consistently, the pYZ1N 
vector was used as a control and showed no cell cycle dif-
ference between gene-repressing (+T) and gene-induc-
ing (−T) conditions.
Rev stimulates the production of reactive oxygen species 
(ROS)
To further explore the possible molecular mechanism 
underlying Rev-induced growth delay, possible intra-
cellular stress induced by Rev was measured by prob-
able production of ROS. A ROS-specific dye, DHE that 
produces red fluorescence in the presence of ROS, was 
used to measure possible cellular oxidative stress in rev-
expressing cells. A ROS scavenger TMPO that can spe-
cifically remove free radicals by forming stable complexes 
[67], was also used as a control to verify the specific pro-
duction of ROS. Expression of HIV-1 rev was induced in 
a fission yeast strain carrying the pYZ1N-rev plasmid, 
and the level of ROS was subsequently detected in cells 
at 21, 24, and 30  h after rev gene induction (Fig.  5). At 
21  h, strong red fluorescence was detected in the rev-
expressing cells; whereas little or no red fluorescence was 
observed in the rev-repressing cells (Fig.  5a). Consist-
ently, treatment of the same rev-expressing cells with the 
ROS scavenger TMPO significantly reduced intensity of 
the red fluorescence suggesting the observed ROS pro-
duction is Rev specific. Interestingly, Rev-induced ROS 
production faded away very quickly (Fig.  5b). About 
half of the rev-expressing cells produced the ROS sig-
nals 21 h after rev gene induction. Less than 30% of the 
cells showed ROS production 3 h later and a little more 
than 10% of those cells were DHE-positive by 30 h after 
gene induction. Together these data suggest expression 
of HIV-1 rev gene in fission yeast triggers intracellular 
oxidative stress. However, such a cellular stress response 
Table 1 Subcellular localization of HIV-1 proteins in mam-
malian and fission yeast cells
a Different subcellular localization pattern was observed.
HIV‑1 protein Subcellular localization
Mammalian (references) Fission yeast (this study)
Gag Cytoplasmic membrane  
[51]
Cytoplasm
P17 Cytoplasm, membrane  
[52]
Cytoplasm
P24 Cytoplasmic membrane  
[53]
Nucleus and cell membrane
P7 Nucleus [54] Nucleus
P6 Cytoplasmic membrane  
[55]
Throughout cella
P66 Cytoplasm [56] Nuclear > cytoplasm
P51 Cytoplasm [56] Cytoplasm
Integrase Nucleus [57] Nuclear > cytoplasm
Protease No report found Throughout cell
Gp120 No report found Nuclear > cytoplasm
Gp41 No report found Nuclear > cytoplasm
Vpr Nucleic membrane [48] Nucleus [58]
Vpu Cytoplasm [59] Cytoplasm
Vif Nucleus [60] Nucleus
Nef Cytoplasm [61] Throughout cella
Rev Nucleus [62] Nucleus
Tat Nucleus [63] Nucleus
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might be transient, which could potentially explain at 
least in part why those rev-expressing cells slowed cell 
growth but did not die.
Effect of Rev protein on mammalian cell growth
Since HIV-1 Rev caused growth delay in S. pombe, we 
were interested in whether the same effect could also be 
observed in mammalian cells. In order to observe the 
effect of Rev protein on mammalian cellular growth, we 
created a mammalian gene inducible system to produce 
Rev. The HIV-1 rev gene was cloned into the mamma-
lian cell expressing vector pZH-1 and transfected into 
293VE632 cells [68]. The transfected cells were selected 
with hygromycin. After exerting drug selection for 
2 weeks, Rev protein production was tested by inducing 
its expression with muristerone A. The cell lysate were 
collected and monoclonal anti-Rev antibody was used 
to confirm the expression of Rev protein (Fig. 6a). It was 
anticipated that if Rev affects mammalian cell growth, 
there should be a difference of cell numbers between 
rev-expressing and rev-repressing cells. The cell num-
bers of rev-containing 293VE632 cells were counted 
with Trypan blue staining under rev-repressing and 
rev-inducing conditions, and growth curves were gener-
ated. Indeed, there was a diverging growth differences 
between rev-expressing and rev-repressing cells after 
5  days of culture (Fig.  6b). Finally, we tested whether 
the Rev-induced growth delay was due to, or at least 
partially due to alteration in cell cycling. To test this, 
293VE632 cells containing pZH-1 and pZH-rev were 



















Fig. 3 Effects of HIV-1 viral proteins on colony formation. Wild type S. pombe cells containing HIV-1 viral gene-expressing plasmids were grown 
overnight in EMM liquid medium supplemented with thiamine to mid-log phase. The following day, cells were recovered, re-suspended in fresh 
media and streaked onto the minimal selection EMM agar plates with thiamine (left +T plates; no gene expression) or without thiamine (right −T 
plates; with gene expression). The plates were incubated at 30°C for 6 days before observation. The pYZ1N-vpr and pYZ1N plasmids were used as 
positive and negative controls, respectively [34].
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cultured under the rev-repressing and rev-inducing con-
ditions. Following gene induction for 5  days, the cells 
were harvested and the DNA contents were measured by 
flow cytometry as described in the materials and meth-
ods. No significant differences in cell cycle distributions 
were seen between rev-expressing and other control 
293VE632 cells (Fig. 6c). Therefore, consistent with our 
observations in fission yeast, Rev also reduces mam-
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Fig. 4 Effect of HIV-1 Rev protein production on fission yeast. a Expression of HIV-1 rev delays cellular growth of S. pombe. S. pombe cells containing 
pYZ1N-rev was grown under gene-repressing (+T) and gene-inducing (−T) conditions in liquid minimal selection EMM at 30°C. The cell density 
was measured over time and growth curves were plotted. S. pombe cell containing pYZ1N was used as a control. The experiment was repeated 
three times and the standard errors of each time point were calculated. b Rev delays colony formation in fission yeast cells. A semi-quantitative 
colony dot dilution assay was use to evaluate the ability of individual rev-expressing S. pombe cells to form colonies on agar plates. The pYZ1N-rev 
transformed S. pombe cells were grown in liquid EMM medium to log phase with thiamine. Thiamine was then removed from cells by washing and 
equal number of cells transferred to EMM supplemented plates with (gene-off, left plate) and without (gene-on, right plate) thiamine. The plates 
were incubated at 30°C for 5 days. Each colony on a plate from left to right (1–6) represents cells plated from approximately 1,000 to 3 cells following 
threefold dilutions. The pYZ1N plasmid was used as a control. c Rev does not affect cell cycle of fission yeast. Cell cycle profiles were measured in 
the pYZ1N-rev and pYZ1N control S. pombe cells by flow cytometric analysis. The data show analyses after 24 and 67 h of cell culture in EMM selec-
tive media with (gene-off ) and without (gene-on) thiamine. The cell cycle stages were monitored after staining with propidium iodide. The up-right 
numbers are the percentage of cells in G1, S and G2 phases of the cell cycle. 
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Discussion
Maintaining faithful viral production during HIV-1 infec-
tion requires highly coordinated production of each 
individual viral protein and orchestration of the entire 
protein complexes. Each viral protein has to interact 
with host cellular proteins at defined subcellular sites 
to ensure successful completion each step of the viral 
life cycle. Identification of subcellular localization of 
all viral proteins encoded by HIV-1 is therefore a key 
































Fig. 5 Expression of rev stimulates production of reactive oxygen 
species (ROS) in S. pombe cells. Fission yeast strain carrying pYZ1N-rev 
was grown in selective EMM either in the presence (+T) or absence 
(−T) of thiamine to suppressor or induce rev gene induction, respec-
tively. a ROS production was detected by addition of a ROS indicator 
dye (DHE) to the culture medium right before microscopic observa-
tion overtime at different times as indicated. An oxygen radical scav-
enger (TMPO) was also added in separate test tubes but concurrently 
to test the specific production of ROS. TMPO was added twice during 
the course of the rev expression. TMPO was first added to the culture 
at the time of cell inoculation when rev gene expression was induced, 
and cells were treated again with TMPO when DHE was added to 
the culture to detect ROS production. DHE DHE-positive cells, DIC 
cells shown by differential interference contrast. Scale bar 10 μm. b 
Percentage of ROS-producing cells induced by HIV-1 Rev decreases 
over time. The % of ROS-producing cells induced by HIV-1 Rev was 
quantified by counting the numbers of DHE-positive cells over the 
















































Fig. 6 Effect of HIV-1 Rev in mammalian cells. a Stable expression 
of HIV-1 rev gene in 293VE632 cells. The inducible pZH-1-rev plasmid 
was transfected into 293VE632 cells. The rev gene was expressed 
following addition of muristerone A and confirmed by Western 
blot analysis using a HIV-1 Rev monoclonal antibody. Lane “Off”, 
rev-repressing 293VE632 cells; lane “On”, rev-expressing 293VE632 
cells. Western blot shows a 13 kDa protein band that was reacted to 
the anti-Rev antibody. β-actin was used as a loading control. b The 
293VE632 cells containing the pZH-1-rev plasmid were grown under 
gene-repressing (rev-Off ) and gene-inducing (rev-On) conditions 
for up to 7 days. The cells were collected every 24 h, and the cell 
numbers were counted with Tryptan blue staining (Sigma-Aldrich) 
[69]. The growth curves were generated with an average of three dif-
ferent experiments. c Rev does not affect mammalian cell cycle. The 
293VE632 cells transfected with pZH-1 and pZH-1-rev plasmids were 
cultured without muristerone A (rev-Off ) or with muristerone A (rev-
On). DNA contents of the cells were determined by flow cytometric 
analyses after 5 days of culture. The upright numbers are the percent-
age of cells in the G1, S and G2 phases of the cell cycle. The 293VE632 
cells containing pZH-1 plasmid was used as a control (upper row).
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production and their potential effects on basic cellular 
functions. Here, we demonstrated the subcellular locali-
zations of all HIV-1 viral proteins in fission yeast cells. 
This might be the first effort to illustrate the subcellular 
localizations of the entire HIV-1 genome all at once in 
a single cellular system. The use of GFP tagging allows 
the selective and specific detection of HIV-1 proteins at 
very low concentrations with good signal-to-background 
ratio. Combined information on HIV-1 viral protein sub-
cellular localization with genome-wide protein–protein 
interaction data will be instrumental in establishing the 
interrelationships between the viral and host cellular pro-
teins that determine virologic functions of the virus [70].
In fission yeast, we observed that HIV-1 P24, P7, P66, 
P51, IN, Gp120, Gp41, Vpr, Vif, Rev and Tat are all pre-
dominantly localized in the nuclei (Fig.  2). Please note 
that nuclear localization of Vpr has long been established 
in our laboratory [48]. It was used as a positive control 
here to confirm appropriate experimental conditions. The 
P17 and Vpu are primarily localized in the cytoplasm, 
which is consistent with previous findings in mammalian 
cells [59]. Also, the Gag precursor protein was seen to 
aggregate in the cytoplasm of unknown sites that resem-
bles mammalian report [51]. The PR and Nef did not 
seem have any preference but distributed throughout the 
cell. Based on the previous reports on subcellular locali-
zations of HIV-1 viral proteins in mammalian cells, there 
is a general correlation between fission yeast and mam-
malian cells (Table 1).
We further examined the potential growth or cyto-
toxic effects of the viral gene expressions on fission yeast 
cells. While most of the HIV-1 viral protein productions 
have no inhibitory effects on colony formation in fis-
sion yeast, Vpr, PR and Rev showed significant inhibitory 
effects (Fig. 3). The effect of Vpr has been studied exten-
sively before [34, 37–40, 48]. Rev was chosen here for fur-
ther analysis (Note: we have carried out subsequent and 
extensive studies on PR that will be described elsewhere).
HIV-1 Rev is an 18 kD phosphoprotein with 116 amino 
acids that contains a nuclear localization signal (NLS) and 
nuclear export signal (NES) [71, 72]. Thus it is capable 
of shutting between the cytoplasm and nucleus where it 
also specifically bind to the Rev responsive element (RRE) 
for nuclear transport of HIV-1 RNAs. In HIV-infected 
cells, HIV-1 Rev protein is located predominantly in 
the nucleus/nucleolus [73–75]. In addition, Rev is also a 
shutting protein between the nucleus and cytoplasm [75]. 
Thus it was not surprising that Rev was found to localize 
predominantly in the nucleus but also in the cytoplasm of 
the fission yeast cells (Fig. 2c, 5th row). Rev is a “nuclear 
regulatory protein” [76]. Mechanistically, Rev was found 
in the nucleus of mammalian and budding yeast cells 
where they both interact with a small nucleoporin-like 
protein hRIP/RAB1 and yRip1p, respectively [62, 77]. 
Thus it would be interesting in the future to test whether 
Rev also interact with a similar nucleoporin-like protein 
in fission yeast. In addition, we found that the produc-
tion of HIV-1 Rev protein appeared to slow down cel-
lular growth in both fission yeast and mammalian cells. 
However, Rev does not appear to induce cell death in 
proliferating cells but reduced the size of yeast colony 
formation (Fig. 4b) and the number of mammalian cells 
(Fig. 6b) presumably due to growth retardation. Consist-
ently, there has been no report of Rev causing death in 
actively dividing mammalian cells. Interestingly, how-
ever, overproduction of Rev has been reported to cause 
death of non-dividing human cells [78]. In an attempt 
to resolve this potential discrepancy, we have explored 
possible molecular mechanism underlying Rev-induced 
growth delay revealed that expression of HIV-1 rev gene 
in fission yeast triggers transient production of ROS indi-
cating fission yeast cells were experiencing intracellular 
oxidative stress upon Rev production (Fig.  5). Typically, 
upon induction of cellular oxidative stress, large amounts 
of ROS are released from mitochondria within the cell 
that often cause cell death [79, 80]. Paradoxically, no cell 
death was observed in the rev-producing cells. One pos-
sible explanation could be due to the rapid dissipation 
of the cellular stress response in continue dividing cells. 
Conceivably, possible accumulation of ROS production 
in non-dividing cells could potentially contribute to the 
cell death caused by Rev [78]. Test of this possibility will 
be our future goal of the study.
Even though Rev causes significant growth delay in fis-
sion yeast (Fig. 4a) and mammalian cells (Fig. 6b), it does 
not affect distributions of neither cell cycles (Figs.  3c, 
6c). Altogether, our data suggested that Rev is a nuclear 
protein that reduces cellular proliferation in both fission 
yeast and mammalian cells. However, it does not affect 
cell cycling with minimal or no cytotoxic effect at least 
in proliferating cells. Future studies on molecular actions 
of HIV-1 Rev are important because expression of HIV-1 
Rev protein is essential for completion of the viral life 
cycle [78, 81]. In particular, by localizing in the nucleus, 
Rev mediates nuclear export of partially spliced and un-
spliced viral transcripts and its nuclear export signal 
allows nucleocytoplasmic shuttling [78, 81]. Therefore, 
Rev plays a pivotal role in viral replication. Conceivably, 
inhibition of its activities should block HIV-1 viral repli-
cation thus infection.
In summary, we successfully cloned and expressed all 
of the HIV-1 viral genes in S. pombe. By using a fission 
yeast inducible nmt1 promoter, we were able to demon-
strate the specific effects of viral proteins on fission yeast. 
In particular, we observed that, most of the viral pro-
teins localized at the same or similar subcellular sites to 
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human cells, suggesting fission yeast could be used as a 
simple and suitable model for future analysis of some of 
the HIV-1 proteins. Interestingly, besides HIV-1 Vpr, we 
found that HIV-1 PR and Rev also inhibit colony forma-
tion of fission yeast. Additional analysis of Rev suggested 
that there are a number of functional resemblances of 
the Rev effect between fission yeast and mammalian 
cells. These physical and similar effects on cellular func-
tions suggest similar molecular mechanism of actions for 
HIV-1 Rev in yeast and mammalian cells, despite their 
evolutionary distance. Therefore, fission yeast might be 




SP223, a wild-type S. pombe strain (h-, ade6-216, leu1-32, 
ura4-294), was used in this study [27, 34]. Standard YES 
complete and EMM minimal media supplemented with 
adenine, uracil, leucine or thiamine (20  µM) when nec-
essary, were used for yeast cell culture and growth. Solid 
Luria–Bertani (LB) medium supplemented with Ampi-
cillin (100 µg/ml) was used for competent E. coli Top 10 
cell transformation. Mammalian 293VE632 cell was used 
to create a rev-inducible gene expression system. This is a 
stable zeocin-resistant mammalian cell line [68] expressing 
a heterodimer of the modified ecdysone receptor (VgEcR) 
and the retinoid X receptor. The heterodimer binds to 
a hybrid ecdysone response element (ECRE) only in the 
presence of the synthetic analogue of ecdysone, murister-
one A, thus leading to induction of HIV-1 rev gene expres-
sion [82, 83]. The mammalian cell lines were maintained in 
Dulbecco’s modified Eagle (DMEM) medium containing 
10% FBS, 100 µg/ml Zeocin (Invitrogen).
Plasmids
pYZ1N and pYZ3N were used as previously described 
[48] for inducible viral gene expressions in fission yeast 
cells. These plasmids carry a no message in thiamine 
(nmt1) promoter. Under this inducible gene expression 
system, viral gene expression can be repressed or induced 
in the presence or absence of thiamine, respectively [65, 
84]. These plasmids carry the leu2 gene as a selection 
marker. In pYZ3N, GFP is fused to the viral gene at its 
5′ end that was used to visualize intracellular location of 
each viral protein. For mammalian studies, a muristerone 
A-inducible gene expression pZH-1 plasmid was used as 
described previously [68].
Molecular cloning of HIV‑1 genes in fission yeast 
and mammalian cells
The plasmid pNL4-3, which carries an entire HIV-1 
genome, was used as a template for viral gene cloning 
with the exception of rev and tat genes. The PSV-Rev 
plasmid, which carries a rev cDNA and originated from 
a HIV-1 cDNA clone pCV1, was used and obtained 
from the NIH AIDS Reagent Program [85]. The ptatC6H 
plasmid carrying the tat cDNA was used, which was a 
gift from Dr. David Pauza and originated from [86]. For 
mammalian studies, the rev gene was cloned in pZH-1 
and gene expression was induced in 293VE632 cells by 
adding 1 µM muristerone A to the growth medium [68].
Recombinant DNA transformation and gene expression
Each of the viral genes was PCR amplified, cloned and 
confirmed by Sanger DNA sequencing. The confirmed 
recombinant DNA was transformed into SP223 cells by 
electroporation using the BTX ECM600 protocol 0226 
[87]. The transformants were selected on a minimal 
selective medium. For viral gene expression, a single 
yeast colony, which carries viral gene-containing plas-
mids, was grown to log phase on specific EMM liquid 
medium supplemented with 20 μM thiamine. The cells 
were then harvested and washed to remove the thia-
mine. Finally, 2 × 105 cells/ml were grown and tested in 
fresh specific EMM liquid medium with thiamine (gene-
Off) and without thiamine (gene-On). The cell suspen-
sions were incubated at 30°C with constant shaking 
before observations.
Subcellular localization of HIV‑1 viral proteins in fission 
yeast
The HIV-1 viral proteins fused to GFP at their 5′ ends 
in pYZ3N were expressed and their subcellular localiza-
tions were visualized by fluorescent microscopy. Prior to 
visualization, the nucleus of the cells were stained with a 
nuclear dye 4′,6′ diamino-2-phenylindole (DAPI). Briefly, 
thiamine was washed out of a log phase culture with dis-
tilled water. The cells were inoculated in a thiamine free 
minimal media and incubated for at least 14 h for gene 
expression. The cells were then collected by spinning at 
3,000 rpm for 5 min and re-suspended in suitable EMM 
medium. For DAPI staining, 5  µl of the cell suspension 
was pipetted onto a glass slide. The cells were heat fixed 
for 1 min at 70°C on a hot plate. The slide was then cooled 
down for a few seconds before counterstained with 1 µg/
ml final concentration of DAPI. A coverslip was applied 
and the cells visualized under a fluorescence micros-
copy. A Leica DMR fluorescence microscope equipped 
with a high performance charge-coupled device camera 
(Hamamatsu) and Open-Lab software (Improvision, Inc., 
Lexington, MA, USA) was used for all imaging analy-
sis. For DAPI, the cells were observed with a Leica A8 
filter with an excitation of 360  nm (ranged from 340 to 
380 nm) and emission of 470 nm (range, 450 to 490 nm). 
For the observation of GFP, a Leica L5 filter, which has an 
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excitation of 480  nm (ranged from 460 to 500  nm) and 
emission of 527  nm (ranged from 512 to 542  nm), was 
used.
Effect of HIV‑1 viral proteins on yeast colony formation
A single yeast colony, which carries viral gene-containing 
plasmids, was picked from a selective minimal plate and 
inoculated overnight in specific EMM liquid medium 
supplemented with thiamine. The following day, 1 ml of 
a mid-log phase culture was spin down, washed three 
times with distilled water and the cells re-suspended in 
appropriate volume of water. About 1–5 µl were streaked 
onto selective EMM plates with and without thiamine. 
The plates were incubated at 30°C for 6 days to observe 
for colony formation and numbers of cells within each 
colony (at low dilutions) as a semi-quantitative indicator 
of the viral effect on cellular growth or cytotoxicity.
Characterization of HIV‑1 Rev protein activities in fission 
yeast
Apart from the colony formation assay on agar plates, 
the effect of Rev on yeast cell proliferation was also 
determined by growth kinetics analyses as previously 
described [34]. Cell cycle profile of rev-expressing cells 
was measured by flow cytometry using a previously 
described method [31, 49]. A semi-quantitative growth 
and colony dot test was also used to quantify the effect 
of Rev on yeast cellular growth and colony formation. 
Briefly, the cells were grown to a log phase in liquid EMM 
as previously described and washed to remove thiamine. 
Cell suspension of 5 × 105 cells/ml was made on a 96 well 
plate and five consecutive threefold dilutions were made. 
Using a multiple pipette, 2  µL spots were generated on 
EMM supplemented media with (gene-off) and without 
(gene-on) thiamine. The plates were incubated at 30°C 
for 5 days to observe for colony formation. Fission yeast 
cells that were transformed with an empty pYZ1N vector 
were used as control. Potential effect of Rev on cellular 
oxidative stress was measured by production of reactive 
oxygen species (ROS), which can be detected by a ROS-
specific dye, dihydroethidium (DHE) that produces red 
fluorescence in the presence of ROS as described previ-
ously [39]. A ROS scavenger, 3,3,5,5-tetramethylpyrroline 
N-oxyde (TMPO) was used as a control to specifically 
remove ROS [71].
Characterization of Rev‑specific activities in mammalian 
cells
A Rev protein-inducible mammalian system was cre-
ated and used for growth kinetics measurement as well 
as for analysis of cell cycle profile. For growth kinet-
ics measurement, the Rev protein was expressed in 
transfected 293VE632 cells following the addition of 
muristerone A. Protein expression was confirmed by 
Western Blot analysis using a monoclonal anti-Rev 
antibody as previously described [40]. Viable cells were 
grown in equal numbers in both rev-inducing and rev-
repressing conditions for 7 days. The number of viable 
cells were counted by observation of differential stain-
ings of the Trypan Blue (Sigma-Aldrich) [69]. Finally, 
for cell cycle profile measurement, 293VE632 cells 
containing pZH-1 (control cells) and pZH-1-rev were 
cultured under rev-repressing and rev-inducing condi-
tions as mentioned before. Following gene induction of 
5 days, the cells were harvested and prepared for flow 
cytometry as described [40, 41]. The DNA contents 
of the cells were analyzed on a FACScan flow cytom-
etry device (Becton–Dickinson) using the Cell Quest 
software.
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